ACLA Press Releases

  • ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar

    October 15, 2019
    Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association (ACLA) has filed a motion for summary judgment before the U.S. District Court for the District of Columbia challenging the flawed implementation of the Protecting Access to Medicare Act (PAMA) in the final rule promulgated by the U.S. DepartmentContinue Reading »...
  • ACLA Deeply Concerned by FDA Actions on Pharmacogenetic Testing

    September 18, 2019
    Agency actions limit clinical information for physicians and patients, undermine Congress and ongoing diagnostic reform efforts Washington, D.C. – In response to the U.S. Food and Drug Administration (FDA)’s troubling actions against pharmacogenetic (PGx) testing, ACLA urged the agency to immediately reconsider and reverse its recent decisions in light of the significant harm and consequences to patient care. Taken together, FDA’s actions appear toContinue Reading »...
  • ACLA Statement in Response to U.S. Court of Appeals Ruling in ACLA v. Azar

    July 30, 2019
    Court of Appeals Says ACLA is Entitled to Challenge HHS’s Harmful Regulatory Overreach  Washington, D.C. — In response to today’s ruling from the U.S. Court of Appeals for the District of Columbia in favor of the American Clinical Laboratory Association (ACLA) in its lawsuit against the Department of Health and Human Services (HHS), ACLA President Julie Khani issued the following statement: “We strongly commend the CourtContinue Reading »...
  • National Health Organizations Call on Congressional Leaders to Delay Flawed Reporting Process Jeopardizing Seniors’ Access to Laboratory Care

    July 17, 2019
    LAB Act would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. – With 53 million Americans facing steep year-over-year cuts to vital clinical diagnostics, 26 national groups representing patient, provider, diagnostic and laboratory organizations called on Congressional leadership to delay a flawed data collection process that continues to erode Medicare lab benefits for the country’s mostContinue Reading »...
  • Reps. Peters, Bilirakis, Pascrell, Schrader, Holding and Hudson Introduce Bipartisan Legislation to Protect Seniors’ Lab Benefits, Improve Data Reporting Under PAMA

    June 28, 2019
    LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates    WASHINGTON, D.C. — With 53 million Americans facing steep year-over-year cuts to vital clinical diagnostics, the American Clinical Laboratory Association (ACLA), AdvaMed, the National Independent Laboratory Association (NILA) and the Point of Care Testing Association applaud new bipartisan legislation introduced to address a flawedContinue Reading »...
  • CDC, Private Sector Laboratory Partners Build on Cross-Sector Collaboration Related to Emergency Preparation & Response

    June 13, 2019
    ATLANTA, G.A. – The Centers for Disease Control and Prevention (CDC) led a tabletop exercise with multiple partners to strengthen diagnostic laboratory surge testing capacity during an emergency response. The purpose of the exercise was to assess the utility of a newly created CDC Emergency Operations Center (EOC) Laboratory Task Force Guide, and to review the processes for commercial clinical laboratories to provide diagnosticContinue Reading »...
  • New Report Highlights Value of Clinical Labs to U.S. Economy

    May 06, 2019
    Washington, D.C. – The American Clinical Laboratory Association (ACLA) today released new economic data highlighting the contributions of clinical laboratories to the economy and the job market in the United States. The findings provide a snapshot of the benefits clinical labs provide to the national economy as well as states and local communities. Clinical laboratories support more than 688,000 jobs in the workforce, bringingContinue Reading »...
  • More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight 

    May 06, 2019
    Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers reiterated the urgent need for Congressional action on a modernized regulatory framework for clinical laboratory diagnostics. Patients have yet to benefit from groundbreaking clinical diagnostics that monitor and support treatment for complex and rareContinue Reading »...
  • ACLA Elects 2019-2020 Board of Directors

    March 28, 2019
    Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2019-2020. Douglas M. VanOort, Chairman and CEO of NeoGenomics Laboratories will take on a new leadership role as ACLA Board Chair, replacing Dr. Curtis Hanson of Mayo Clinic Laboratories. Jerry Hussong, CEO of Sonic Healthcare USA was elected Vice Chair and John Kolozsvary, CEOContinue Reading »...
  • ACLA Files Reply Brief Ahead of Oral Arguments in ACLA v. Azar Appeal

    March 18, 2019
    HHS’ data collection process under PAMA disregards Congressional intent, jeopardizing lab access for millions of seniors Washington, D.C. – The American Clinical Laboratory Association (ACLA) filed a reply brief today ahead of oral arguments in the ACLA v. Azar appeal which has been scheduled for April 23, 2019. The brief reinforces ACLA’s argument that the U.S. Department of Health and Human Services (HHS) failedContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16